phosphodiesteras iii inhibit adrenoreceptor stimul milrinon altern treatment sever heart failur high level endogen plasma catecholamin patient sever congest heart failur down-regul myocardi beta-adrenoreceptor adrenoreceptor agonist dobutamin effect treatment patient phosphodiesteras iii inhibitor independ adrenoreceptor activ plasma catecholamin level agent like effect treatment sever heart failur present studi initi late hemodynam effect dobutamin milrinon infus patient sever heart failur new york heart associ class iii new york heart associ class IV dobutamin prescrib maximum dose micrograms/kg/min hour patient patient dose dobutamin infus drug-rel increas heart rate beats/min patient hemodynam improv hour maximum dose micrograms/kg/min dobutamin administr patient account unfavor hemodynam condit therapi intraven milrinon patient side effect comparison hemodynam effect infus possibl patient patient observ period increas heart rate beats/min hour equal dobutamin increas milrinon stroke volum dobutamin infus hour hour milrinon therapi volum equal level end infus pulmonari capillari wedg pressur pcwp equal milrinon therapi mm Hg minut mm Hg hour dobutamin infus pcwp delay decreas mm Hg hour mm Hg hour abstract truncat AT word 